Medicare Enrolled
Dr. Barry Shuman, MD
Urology Physician · Albany, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shuman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shuman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shuman
Dr. Barry Shuman is an urology physician in Albany, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Shuman performed 1,837 Medicare services across 1,358 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shuman received a total of $9,360 from 49 pharmaceutical and/or device companies across 446 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shuman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 37% volume in NY
$9,360 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,837
Medicare services
Top 37% in NY for urology physician
1,358
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~92 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
556 | $3 | $8 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
392 | $61 | $175 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
155 | $2 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
120 | $85 | $233 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 99 | $134 | $307 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
94 | $159 | $321 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
61 | $61 | $172 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
48 | $65 | $229 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
44 | $11 | $49 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
42 | $19 | $50 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
31 | $66 | $240 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
23 | $26 | $63 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $101 | $310 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
20 | $39 | $89 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
17 | $103 | $1,008 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
16 | $8 | $37 |
| Bladder/urethra growth removal via endoscope, 0.5-2.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 0.5 and 2.0 centimeters. |
16 | $173 | $492 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
16 | $113 | $7,487 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $32 | $126 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
14 | $24 | $96 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
13 | $564 | $1,687 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $118 | $327 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
11 | $44 | $123 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
8.4% medium
90.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,360
Total received (2018-2024)
Avg $1,337/year across 7 years
Top 19% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
446
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,345 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,398
2023
$1,401
2022
$1,656
2021
$1,439
2020
$659
2019
$1,103
2018
$1,704
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Myriad Genetic Laboratories, Inc.
$291
Antares Pharma, Inc.
$223
Merck Sharp & Dohme LLC
$155
Ferring Pharmaceuticals Inc.
$144
Sumitomo Pharma America, Inc.
$110
Janssen Biotech, Inc.
$110
UROGEN PHARMA, INC.
$71
Tolmar, Inc.
$50
180 Medical, Inc.
$49
PFIZER INC.
$45
Axonics, Inc.
$40
Boston Scientific Corporation
$31
Teleflex LLC
$31
Medtronic, Inc.
$25
Endo USA, Inc.
$24
Top 3 companies account for 47.8% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$987
PFIZER INC.
$735
Antares Pharma, Inc.
$719
Janssen Biotech, Inc.
$468
Myriad Genetic Laboratories, Inc.
$390
180 Medical, Inc.
$326
Merck Sharp & Dohme LLC
$307
UROVANT SCIENCES INC
$305
UroGen Pharma, Inc.
$302
AbbVie Inc.
$298
AbbVie, Inc.
$295
Sumitomo Pharma America, Inc.
$289
Supernus Pharmaceuticals, Inc.
$266
BOSTON SCIENTIFIC CORPORATION
$245
NeoTract Inc.
$239
Amgen Inc.
$233
Endo Pharmaceuticals Inc.
$230
Teleflex LLC
$230
TOLMAR Pharmaceuticals, Inc.
$217
Myovant Sciences Inc.
$165
PROCEPT BioRobotics Corporation
$165
Ferring Pharmaceuticals Inc.
$156
Boston Scientific Corporation
$146
Bayer HealthCare Pharmaceuticals Inc.
$129
Allergan Inc.
$126
Tolmar, Inc.
$119
Coloplast Corp
$107
ABBVIE INC.
$98
Hollister Incorporated
$92
Allergan, Inc.
$90
Blue Earth Diagnostics Limited
$80
Medtronic, Inc.
$80
Axonics Modulation Technologies, Inc.
$76
Mission Pharmacal Company
$71
UROGEN PHARMA, INC.
$71
Medtronic USA, Inc.
$61
Axonics, Inc.
$58
Merck Sharp & Dohme Corporation
$53
C. R. Bard, Inc. & Subsidiaries
$50
Retrophin, Inc.
$44
DENTSPLY IH Inc.
$40
Avadel Specialty Pharmaceuticals, LLC
$39
Rochester Medical Corporation
$29
COLOPLAST CORP
$28
Travere Therapeutics, Inc.
$25
Endo USA, Inc.
$24
Zyla Life Sciences, Inc.
$23
Laborie Medical Technologies Corp.
$20
TherapeuticsMD, Inc.
$14
Top 3 companies account for 26.1% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BIJUVA · BOTOX · BOTOX THERAPEUTIC · CONTINENCE CARE · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL ONCOLOGY · GENERAL THERAPIES · GENERAL BPH · GENTLECATH · GENTLECATH GLIDE · General - BPH · GentleCath · INTERSTIM · Infyna Chic · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · MYRISK · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ONLI · ORGOVYX · OTREXUP · Otrexup · PROLARIS · Prolaris · Prolia · Rezum Generator · SKYLITE · SPEEDICATH · SPRIX · SpaceOAR VUE System - 10mL · SpeediCath · TLANDO · Thiola · UROLIFT · Uribel · UroLift · UroLift System · Urocit-K · VAPRO · VaPro · VaPro Pocket · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
44
Per 100K population
14.0
County median income
$83,149
Nearest hospital
ALBANY MEDICAL CENTER HOSPITAL
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shuman is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 19% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shuman experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Shuman performed 556 urinalysis, manual services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shuman receive payments from pharmaceutical companies?
Yes. Dr. Shuman received a total of $9,360 from 49 companies across 446 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shuman's costs compare to other urology physicians in Albany?
Dr. Shuman's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shuman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Albany
Browse urology physicians in Albany ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Antares Pharma, Inc. Payments to Doctors
See all physicians who received payments from Antares Pharma, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology